Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (Q41827081)
Jump to navigation
Jump to search
scientific article published on September 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system |
scientific article published on September 1999 |
Statements
1 reference
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system (English)
1 reference
Culig Z
1 reference
Hoffmann J
1 reference
Erdel M
1 reference
Eder IE
1 reference
Hobisch A
1 reference
Hittmair A
1 reference
Bartsch G
1 reference
Utermann G
1 reference
Schneider MR
1 reference
Parczyk K
1 reference
Klocker H
1 reference
1 September 1999
1 reference
1 reference
242-251
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference